Genome-wide profiling in colorectal cancer identifies PHF19 and TBC1D16 as oncogenic super enhancers
Active enhancers are still understudied in colorectal cancers (CRC). Here the authors analyse active enhancers in CRC patients using genomics, transcriptomics, and epigenomics, identifying and validating variant super-enhancer loci as well as KLF3 as a relevant transcription factor.
Guardado en:
Autores principales: | Qing-Lan Li, Xiang Lin, Ya-Li Yu, Lin Chen, Qi-Xin Hu, Meng Chen, Nan Cao, Chen Zhao, Chen-Yu Wang, Cheng-Wei Huang, Lian-Yun Li, Mei Ye, Min Wu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/674cf176220842dd92978ff6bc45defa |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
PHF5A promotes colorectal cancerprogression by alternative splicing of TEAD2
por: Yue Chang, et al.
Publicado: (2021) -
Formation Mechanism for 2015/16 Super El Niño
por: Lin Chen, et al.
Publicado: (2017) -
Phf8 histone demethylase deficiency causes cognitive impairments through the mTOR pathway
por: Xuemei Chen, et al.
Publicado: (2018) -
Eliminating blood oncogenic exosomes into the small intestine with aptamer-functionalized nanoparticles
por: Xiaodong Xie, et al.
Publicado: (2019) -
TBC pulmonar infantil
por: IBAÑEZ Q,SERGIO
Publicado: (1973)